Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ritalin LA Will Be Novartis’ Second Marketed Once-Daily Methylphenidate

Executive Summary

Novartis' Ritalin LA will be the company's second once-daily methylphenidate formulation on the market

You may also be interested in...



Metadate CD sprinkling (correction)

Celltech's Metadate CD, like Novartis' Ritalin LA, can be sprinkled on applesauce. Celltech's once-daily methylphenidate ADHD agent received supplemental approval for applesauce sprinkling on April 9 (1"The Pink Sheet" June 10, p. 6)...

Metadate CD sprinkling (correction)

Celltech's Metadate CD, like Novartis' Ritalin LA, can be sprinkled on applesauce. Celltech's once-daily methylphenidate ADHD agent received supplemental approval for applesauce sprinkling on April 9 (1"The Pink Sheet" June 10, p. 6)...

Novartis Focalin Price Similar To Ritalin; ADHD Drug Clears FDA Nov. 13

Novartis' Focalin will be priced similarly to its parent compound Ritalin, the company said following the Nov. 13 approval of the attention deficit hyperactivity disorder drug

Related Content

UsernamePublicRestriction

Register

OM017301

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel